Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
| Status | Patent |
|---|---|
Application | Utility: TUMOR MUTATION BURDEN ALONE OR IN COMBINATION WITH IMMUNE MARKERS AS BIOMARKERS FOR PREDICTING RESPONSE TO TARGETED THERAPY Filling date: 23 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) AND CD22 CAR COMBINATION THERAPIES Filling date: 23 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: PROCESS OF MANUFACTURE OF A COMPOUND FOR INHIBITING THE ACTIVITY OF SHP2, AS WELL AS PRODUCTS RESULTING FROM ACID ADDITION Filling date: 23 Sep 2025 Issue date: 11 Nov 2021 |
Application | Utility: Fused Tricyclic Pyrazolo-Dihydropyrazinyl-Pyridone Compounds as Antivirals Filling date: 23 Sep 2025 Issue date: 11 Nov 2021 |
Grant | Utility: Entry cannula with intraocular pressure activated seal Filling date: 23 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Factor XI antibodies and methods of use Filling date: 23 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Ophthalmic illumination system with controlled chromaticity Filling date: 23 Sep 2025 Issue date: 9 Nov 2021 |
Application | Utility: METHODS FOR TREATING OCULAR DISEASES Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: CRYSTALLINE FORMS OF A TRIAZOLOPYRIMIDINE COMPOUND Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: GFRAL EXTRACELLULAR DOMAINS AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 4 Nov 2021 |
Grant | Utility: Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal Filling date: 23 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Polyomavirus neutralizing antibodies Filling date: 23 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Pharmaceutical dosage forms Filling date: 23 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Pyridinone derivatives and their use as selective ALK-2 inhibitors Filling date: 23 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Regimens and methods of treating multiple sclerosis using ofatumumab Filling date: 23 Sep 2025 Issue date: 2 Nov 2021 |
Grant | Utility: Car-expressing cells against multiple tumor antigens and uses thereof Filling date: 23 Sep 2025 Issue date: 2 Nov 2021 |
Application | Utility: Pharmaceutical Compositions and Pharmaceutical Products of Heterodimeric Human Interleukin-15 (hetIL-15) Filling date: 23 Sep 2025 Issue date: 28 Oct 2021 |
Grant | Utility: Method of detecting TIM-3 using antibody molecules to TIM-3 Filling date: 23 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Cell bag rotator Filling date: 23 Sep 2025 Issue date: 26 Oct 2021 |
Application | Utility: ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: ANTIVIRAL 1,3-DI-OXO-INDENE COMPOUNDS Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BE- NZYL]-AZETIDINE-3-CARBOXYLIC ACID Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: UREA COMPOUNDS AND COMPOSITIONS AS SMARCA2/BRM ATPASE INHIBITORS Filling date: 23 Sep 2025 Issue date: 21 Oct 2021 |
Grant | Utility: Surgical suite integration and optimization Filling date: 23 Sep 2025 Issue date: 19 Oct 2021 |
Application | Utility: METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: ENHANCED ANTIGEN PRESENTING ABILITY OF RNA CAR T CELLS BY CO-INTRODUCTION OF COSTIMULATORY MOLECULES Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: USE OF IL-1 BETA BINDING ANTIBODIES FOR TREATING PERIPHERAL ARTERIAL DISEASE Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: MEANS AND METHOD FOR PRODUCING AND PURIFYING VIRAL VECTORS Filling date: 23 Sep 2025 Issue date: 14 Oct 2021 |
Grant | Utility: Surgical guidance and planning software for astigmatism treatment Filling date: 23 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: USE OF IL-1B BINDING ANTIBODIES FOR THE TREATMENT OF ALCOHOLIC HEPATITIS Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: METHODS FOR PREVENTING AND TREATING HEART DISEASE Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: NLRP3 INFLAMMASOME INHIBITORS Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS Filling date: 23 Sep 2025 Issue date: 7 Oct 2021 |
Grant | Utility: Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same Filling date: 23 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Multi-core fiber for a multi-spot laser probe Filling date: 23 Sep 2025 Issue date: 5 Oct 2021 |
Grant | Utility: Inhibitors for treating diseases characterized by atrial enlargement or remodeling Filling date: 23 Sep 2025 Issue date: 5 Oct 2021 |
Application | Utility: BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS Filling date: 23 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: CRYSTALLINE FORMS OF A LTA4H INHIBITOR Filling date: 23 Sep 2025 Issue date: 30 Sep 2021 |
Grant | Utility: Nucleic acids encoding FGF21-Fc fusion proteins Filling date: 23 Sep 2025 Issue date: 28 Sep 2021 |
Application | Utility: USE OF IL-1BETA BINDING ANTIBODY CANAKINUMAB FOR TREATING OR ALLEVATING SYMPTOMS PULMONARY SARCOIDOSIS Filling date: 23 Sep 2025 Issue date: 23 Sep 2021 |
Grant | Utility: Compounds and compositions for the treatment of parasitic diseases Filling date: 23 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Method of treating transplant rejection with silent Fc variants of anti-CD40 antibodies Filling date: 23 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Customized ophthalmic surgical profiles Filling date: 23 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Antibody-cytokine engrafted proteins and methods of use for immune related disorders Filling date: 23 Sep 2025 Issue date: 21 Sep 2021 |
Showing 250 to 300 of 1223 patents.